Clinical Trials Browser

Phase 1/2 × Neoplasms, Plasma Cell × Heparin × Clear all

NCT00790842 2018-10-24

PrE1003

Phase 1/2 Terminated

63 enrolled 14 charts

Multiple Myeloma, Neoplasms, Plasma Cell